AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

PharmaCyte Biotech, Inc.

$0.30 -$0.44 (-59.07%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$0.33
Day Range
$0.30$0.33
Year Range
$0.30$1.51
Market Cap
3.24M
AVG Volume
165.23K
Trailing/Forward PE
-0.13/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-12-16
Primary Exchange
NASDAQUS
Net Income (USD) · A
-20M020M40M2017201820192020202120222023202420252026
PMCB Net Income (USD) by year
PeriodNet Income (USD)
2026-19.42M
202530.66M
2024334K
2023-3.09M
2022-4.19M
2021-3.55M
2020-3.83M
2019-4.07M
2018-6.83M
2017-4.44M
Operating Income (USD) · A
-10M-7.5M-5M-2.5M02017201820192020202120222023202420252026
PMCB Operating Income (USD) by year
PeriodOperating Income (USD)
2026-6.85M
2025-4.38M
2024-8.52M
2023-6.46M
2022-4.39M
2021-3.62M
2020-3.83M
2019-4.1M
2018-6.98M
2017-4.44M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PMCB

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 16 Dec 2026.

PharmaCyte Biotech, Inc.
PMCB
Stockpicker

Video analysis: PMCB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PMCB

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.